Cetirizine Hydrochloride
- Product NDC
- 66336-336
- 11-digit product format
- 663360336
- Labeler code
- 66336
- Product ID
- 66336-336_64486ca9-85d5-40d1-9a5b-01d52521ed7b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dispensing Solutions, Inc.
- Application
- ANDA077946
- Marketing category
- ANDA
- Marketing start
- 2007-12-27
- Marketing end
- 0000-00-00
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66336-336-14 | Cetirizine Hydrochloride | 14 in 1 BOTTLE | TABLET | 14 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CETIRIZINE HYDROCHLORIDE | ACTIVE INGREDIENT | 64O047KTOA | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| CETIRIZINE | ACTIVE MOIETY | YO7261ME24 | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| POLYETHYLENE GLYCOLs | INACTIVE INGREDIENT | 3WJQ0SDW1A | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66336-336 | CETIRIZINE HYDROCHLORIDE TABLET [DISPENSING SOLUTIONS, INC.] | 3 | Legacy NDC, 1 package rows | 20120928_dd37b7c4-00d6-4a69-8213-713db5725e7c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 66336-336-14 | 66336033614 | 14 in 1 BOTTLE | Historical |